# Yirdoc

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yirdoc

- Industry: Medical Devices & Equipment
- Headquarters: Qingdao, China
- Website: www.yirdoc.cn
- Latest round: Series B (May 7, 2024)
- Investors on record: 1

## About

Based in Qingdao, China, and founded in 2014, Qingdao Future Medical Technology Co., Ltd., trading as Yirdoc, is a smart medical device developer, dedicated to providing digital solutions for chronic respiratory diseases. The company has set up a production center in Changsha, and a business center in Boston. It has obtained more than 60 patents, including patents for nebulizer tablets, performance patents for nebulizers, international PCT patents, etc., and NMPA, FDA, CE and other certifications. In March 2026, Yirdoc raised Series B+ funding from Qingdao Caitong Group.

The company focuses on the field of chronic diseases, providing users with wireless medical solutions. Based on its Clover Spray atomizer technology, two valves and one canister patented technology, and digital monitoring technology, the company has built two major series of products, VM series and NEB series. Its main product is a smart nebulizer, which utilizes IoT technology to interface with chronic disease management platforms. Yirdoc also provides full life-cycle DTF services for inhalation pharmaceutical companies, including preclinical laboratory nebulization parameter analysis and DTF feasibility analysis services. The products are exported to more than 60 countries, including the United States, the European Union, Australia, South Korea, India and Saudi Arabia.
The company generates revenue by offering intelligent nebulizers and full-lifecycle specialized medication services.

## Funding rounds

- Series B, May 7, 2024 — Junxingjian Venture Capital

## Investors

- Junxingjian Venture Capital (https://capitalatlas.ai/funds/junxingjian-venture-capital) — Series B